Phase I dose-escalation study of aflibercept plus docetaxel in nasopharyngeal carcinoma and other solid tumors.
Huang Y, Zou BY, Zhao LP, Zhao HY, Zhao YY, Xue C, Zhang JW, Xu F, Chen LK, Liu JL, Hu ZH, Wu X, Zhang J, Ma YX, Wei CL, Ma Y, Zhang L.
Huang Y, et al. Among authors: xue c.
Future Oncol. 2014 Dec;10(16):2579-91. doi: 10.2217/fon.14.206.
Future Oncol. 2014.
PMID: 25531046
Clinical Trial.